Chronic Kidney Disease—Mineral and Bone Disorder (CKD-MBD), from Bench to Bedside

Chronic kidney disease—mineral and bone disorder (CKD-MBD) is a systemic that increases the risk of morbidity mortality in dialysis patients. CKD-MBD highly prevalent patients, appropriate treatment important for improving their outcomes. Inorganic phosphate, fibroblast growth factor 23, parathyroid hormone, calciprotein particles are markers critical components effectors CKD-MBD, higher circulating levels these linked to cardiovascular diseases. In this short review, we focus on pathogenesis management CKD especially those therapy, discuss prospects including dialysis.